Kelsie Murphy, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-962-1242 |
Gabrielle Marie Spears, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-962-1242 |
Anna Nance, APRN-CNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 184 Unser Blvd Ne, Rio Rancho, NM 87124 Phone: 505-896-0928 |
Sarah Alexander, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-962-1242 |
Mr. Stephen Anthony Spears, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1550 Bridger Rd Ne, Rio Rancho, NM 87144 Phone: 505-850-5305 |
Sarah Manik, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-896-0667 |
Julee Lynn Amador, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-896-0667 |
Catherine Mary Yarmey-legg, RN Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 1621 Saratoga Dr Ne, Rio Rancho, NM 87144 Phone: 505-321-6540 |
Ann Marie Graham, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-896-0667 |
Jennifer Nicole Gibeson, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-962-1242 |
Amanda Chavez, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-962-1242 |
Jeriann C Peter, FNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 7555 Enchanted Hills Blvd Ne Ste 104, Rio Rancho, NM 87144 Phone: 505-771-9833 |
Joaquin Damon Kline, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3752 Clear Creek Rd Ne, Rio Rancho, NM 87144 Phone: 954-740-1404 |
Shelley Arlene Martinez, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-962-1242 |
Mfanelo Phindile Mahla, Registered Nurse - Medical-Surgical Medicare: Not Enrolled in Medicare Practice Location: 3001 Broadmoor Blvd Ne, Rio Rancho, NM 87144 Phone: 505-994-7000 |
Lori Ann Mccain, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-896-0667 |
Patricia Ann Bandy, Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 1600 Loma Colorado Blvd Ne, Rio Rancho, NM 87144 Phone: 505-891-5335 Fax: 505-891-1180 |
Jennifer Lynn Smith, RN Registered Nurse - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 7329 Donet Dr Ne, Rio Rancho, NM 87144 Phone: 505-200-1104 |
Zach Pickett, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 2400 Unser Blvd Se, Rio Rancho, NM 87124 Phone: 505-253-7878 |
Elizabeth Vargas, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-896-0667 |
News Archive
Protalix BioTherapeutics, Inc.,a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell based expression system, today announced that the Company's common stock has been approved for listing on the Tel Aviv Stock Exchange in addition to its current listing on the NYSE Amex.
New data from the Phase III EMBRACA trial led by researchers at The University of Texas MD Anderson Cancer Center found the PARP inhibitor talazoparib did not demonstrate a statistically significant overall survival (OS) benefit for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.
The ability to visualize and analyze the spread of viral infections in primary and metastatic tumors is an essential component in characterizing the therapeutic efficacy of oncolytic viruses.
ASLAN Pharmaceuticals Pte Ltd, a pharmaceutical company headquartered in Singapore, and Bristol-Myers Squibb Company today announced an innovative strategic partnership allowing for the rapid development of BMS-777607, Bristol-Myers Squibb's investigational small molecule inhibitor of the MET receptor tyrosine kinase for treatment of solid tumors.
› Verified 1 days ago